Jin Medical International
ZJYL
12 hedge funds and large institutions have $4.79M invested in Jin Medical International in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 2 closing their positions.
51% more capital invested
Capital invested by funds: $3.17M → $4.79M (+$1.62M)
0.36% more ownership
Funds ownership: 0.78% → 1.14% (+0.36%)
0% more funds holding
Funds holding: 12 → 12 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.13M |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
+$14.7K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.92K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$214K |
| 2 |
WG
Winton Group
London,
United Kingdom
|
-$135K |
| 3 |
Squarepoint
New York
|
-$86.4K |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$7.82K |
| 5 |
Morgan Stanley
New York
|
-$2.53K |
ZJYL Hedge Fund Activity: Q3 2024 in Review
12 of the 6,981 institutional investors tracked by Wall St. Rank reported a position in Jin Medical International (ZJYL) for Q3 2024, worth a combined $4.79M — up 51% from $3.17M a quarter earlier.
Fund positioning in ZJYL was balanced in Q3 2024: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 5 trimmed.
The largest buyer was Vanguard Group, adding an estimated $2.13M. The largest seller was UBS Group, cutting an estimated $214K.
- 12 institutional investors held Jin Medical International (ZJYL) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $4.79M of Jin Medical International stock for Q3 2024, up 51% quarter-over-quarter.
- 2 funds opened new Jin Medical International positions in Q3 2024 and 2 closed out, a net change of 0 holders.
- The largest Jin Medical International buyer in Q3 2024 was Vanguard Group, an estimated $2.13M added.
- The largest Jin Medical International seller in Q3 2024 was UBS Group, an estimated $214K sold.
Based on aggregated 13F filings for Q3 2024.